作用机制,效力和疗效:对细胞疗法的考虑
Carl G Simon1, Erich H Bozenhardt2, Christina M Celluzzi3
1Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD, USA. carl.simon@nist.gov.
Journal of translational medicine
|May 2, 2024
概括
开发先进的细胞疗法产品 (CTP) 需要明确的作用机制 (MOA),效力和疗效的定义. 这种观点提供了一个以计量学为基础的框架,以澄清这些概念并改善CTP的开发.
科学领域:
- 生物技术是生物技术.
- 细胞疗法细胞疗法
- 监管科学 监管科学
背景情况:
- 定义作用机制 (MOA),效力和疗效对于先进细胞疗法产品 (CTP) 开发至关重要.
- 现有的监管指南以及美国FDA批准的27个CTP的经验教训为这一观点提供了信息.
- 对这些概念的误解可能会使开发和临床试验复杂化.
研究的目的:
- 在CTP开发中检查和澄清MOA,功效和疗效的概念.
- 为理解这些关键的产品属性提供基于计量学的框架.
- 改善沟通,并为CTP开发人员设置现实的期望.
主要方法:
- 对27个FDA批准的CTP的MOA,功效和疗效数据的审查.
- 引入功效和疗效过程图表,以说明关键概念关系.
- 分析强度测试与临床结果之间的潜在脱节.
主要成果:
- 提出了一个逻辑框架,以使MOA,功效和疗效与监管期望保持一致.
- 功效和疗效过程图表澄清了MOA,功效,测试,疗效,终点和测试之间的关系.
- 这些例子说明了诸如"强效但不有效"和"不强效但有效"之类的场景.
结论:
- 在人类中确定MOA存在重大挑战,正如不同研究模型的比较评估所表明的那样.
- 仔细考虑MOA,功效和疗效的定义有助于将功效测试结果与临床结果相关联.
- 拟议的框架有助于CTP开发人员设定适当的期望,避免假设,并加强团队沟通.
相关概念视频
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
T Cell Activation and Clonal Selection
714
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
714
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


